project |
|
|---|---|
|
Name/scientific name |
DAUNORUBICIN
|
|
Self-financed or subsidized by the Hospital Authority |
Hospital Authority Drug Formulary
|
|
Indications |
acute lymphoblastic leukemia, acute myelogenous leukemia
|
|
body system |
Cancer and immune system
|
|
type |
Cytotoxic drugs
|
Daunorubicin is a chemotherapy drug used to treat a variety of cancers. It is a type of anti-tumor antibiotic that works by preventing the growth and spread of cancer cells. Donobicin is commonly used to treat hematological malignancies such as leukemia and lymphoma. Patients usually receive an intravenous injection of donobicine in the hospital, and the doctor will determine the dosage and frequency based on the patient's condition and physical condition. While receiving donobicin, patients may experience some side effects, including vomiting, hair loss, and an increased risk of infection. It is important that patients follow their doctor's advice closely and have regular monitoring and check-ups while taking the medication. If you have any questions or discomfort, seek help from your doctor immediately.
How to use: Daunorubicin is an injectable drug that needs to be injected by a health care professional in a hospital or clinic. It is usually given every three to four weeks, and the specific frequency and dosage should be determined according to the physician's instructions. Before the injection, the medical staff will check your physical condition to ensure that you are suitable for receiving the medication.
Dosage Guidelines: In general, the dosage of Daunorubicin is based on the patient's body weight, medical condition, and disease severity. For adults, the initial dose is usually 45-60 mg/m2 of body surface area, administered daily for 1-3 days. For children, the dosage is based on body weight, usually 25-45 mg per square meter of body surface area. The dosage may be adjusted based on patient response and tolerance, please strictly follow your physician's recommendations. During use, contact with the drug, food and activities should be avoided. If you need further guidance, please consult a physician.
Daunorubicin is a drug used to treat leukemia and lymphoma, but it has some side effects to be aware of. After taking Daunorubicin, some patients may experience dizziness, nausea, vomiting, and headache. In addition, Daunorubicin may also affect heart function and cause heart problems. Some patients may suffer from anemia, fatigue and bruising easily. If you experience any of the above side effects or other uncomfortable conditions, you should contact your doctor immediately. Remember, when using Daunorubicin, you need to closely monitor your physical condition and communicate with your doctor to ensure safe use of the drug.
DAUNORUBICIN is a drug used to treat leukemia and other cancers, but there are contraindications when using it. Contraindications include pregnant and lactating women as DAUNORUBICIN may cause harm to the fetus or infant. At the same time, patients who are allergic to this drug or have severe bone marrow suppression should also avoid its use. Patients with heart disease, liver disease, or kidney disease should seek medical advice before use as these conditions may affect the safety and effectiveness of the drug. In addition, interactions with other drugs are also factors that need to be considered. Patients should inform their doctors about other drugs they are taking when using DAUNORUBICIN to avoid the occurrence of adverse reactions. Overall, following your doctor's advice and prescription directions is key to ensuring safe and effective use of DAUNORUUBICIN.
Precautions for use: Donorubicin is a chemotherapy drug used to treat leukemia and other cancers. Please strictly follow your doctor's instructions and do not adjust the dosage or stop using it on your own. Blood indicators should be monitored during use. Side effects such as infection and bleeding may occur. If you feel uncomfortable, please inform your doctor immediately. Women who are pregnant or breastfeeding should avoid using this medication.
We are the first medical service company in Hong Kong that can complete appointment, communication and payment all through mobile phones. You can easily make an appointment for nursing services through your mobile phone in as little as 3 minutes. The whole process can be done by mobile phone. There is no need to make phone calls and wait for an agency to respond to the selection of medical staff.
traditional care agency
careEASY
Registered Nurse (12 hours)
$3300
$2900(-12%)
Enrolled Nurse (12 hours)
$2900
$2600(-10%)
Health Assistant (12 hours)
$1600
$1200 (-25%)
Transparent fees
Free choice of medical care candidates
Communicate directly with healthcare providers
Single service charge
Credit Card/Apple Pay
Donobisine should be avoided during pregnancy. This drug may cause serious risks to the fetus. If you are pregnant or plan to become pregnant, you should tell your doctor right away. During pregnancy, your doctor may recommend stopping use of doxorubicin to avoid any potential effects on your baby. Please be sure to discuss it with your doctor in detail before using this medication and follow your doctor's recommendations. If you become pregnant while taking doxorubicin, notify your doctor immediately so they can help you develop an appropriate management plan. Remember, extra caution is needed during pregnancy, especially when it comes to medication use, to ensure the health of both mother and baby.
No longer restricted by traditional medical care intermediaries, doctors, nurses and customers also have the right to choose! You can also make remote reservations via mobile phone when you are away from home, no need to call to make reservations for family members!
©2024 All Rights Reserved. Created with LOVE and coffee in 🇭🇰